Immunostimulatory CpG on Carbon Nanotubes Selectively Inhibits Migration of Brain Tumor Cells
Darya Alizadeh(CTI BioPharma (United Kingdom)), Jacob M. Berlin(City Of Hope National Medical Center), Shunan Liu(Jilin University), Leying Zhang(City Of Hope National Medical Center), Teresa Cos Sanchez(City Of Hope National Medical Center), Behnam Badie(City Of Hope National Medical Center), Ethan E. White(City Of Hope National Medical Center)
Cited by 29
Related Papers
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754
IL15 Enhances CAR-T Cell Antitumor Activity by Reducing mTORC1 Activity and Preserving Their Stem Cell Memory Phenotype
|Cancer Immunology Research|2019|437
Chimeric Antigen Receptors T Cell Therapy in Solid Tumor: Challenges and Clinical Applications
|Frontiers in Immunology|2017|216